ALIREGFENIB
- Strength
- 40mg
- Manufacturer
- Availability
- Available to source
ALIREGFENIB 40mg — 28片
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
1. Indicated for patients with metastatic colorectal cancer (mCRC) previously treated with fluorouracil-, oxaliplatin- and irinotecan-based chemotherapy, and who have received or are not candidates for anti-VEGF therapy and anti-EGFR therapy (RAS wild-type). 2. Patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumour (GIST) previously treated with imatinib mesylate and sunitinib malate. 3. Patients with hepatocellular carcinoma (HCC) previously treated with sorafenib.
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
Related medicines
